NRBP1 and bladder transitional cell carcinoma: Finally, we analyzed the correlation between the expression levels of NRBP1 in patients with bladder urothelial carcinoma (BLCA)and the overall survival using the Cancer Genome Atlas (TCGA) database, and found that low-medium expression of NRBP1 was associated with better prognosis (Fig. 1E).